You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 3, March 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Macular Degeneration
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Vitamin E and the Age-Related Eye Disease Study Supplementation for Age-Related Macular Degeneration

Arch Ophthalmol. 2005;123:395-396.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

An oral presentation at the November 2004 meeting of the American College of Physicians in New Orleans, La, which summarized a meta-analysis of controlled clinical trials of vitamin E, received much attention from the press, with headlines such as "Vitamin E Supplements Might Kill You" and "Vitamin E Can Be Deadly." The article,1 published in the January 2005 edition of the Annals of Internal Medicine, reports that taking high-dose vitamin E supplements does not lower the risk of death and might be associated with a small increase in the risk of death. These study conclusions have resulted in confusion among the treating physicians and persons who are at moderate or high risk for developing age-related macular degeneration (AMD) and who are taking the Age-Related Eye Disease Study (AREDS) supplements that include 400 international units (IU) of vitamin E daily.2

In this new study, the authors conducted a meta-analysis to . . . [Full Text of this Article]


AUTHOR INFORMATION
Emily Y. Chew, MD; Traci Clemons, PhD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Heart Outcomes Prevention Evaluation–The Ongoing Outcomes Study, Vitamin E, and Age-Related Macular Degeneration
Jose S. Pulido
Arch Ophthalmol. 2006;124(11):1665.
EXTRACT | FULL TEXT  

Heart Outcomes Prevention Evaluation–The Ongoing Outcomes Study, Vitamin E, and Age-Related Macular Degeneration—Reply
Emily Y. Chew and Traci E. Clemons
Arch Ophthalmol. 2006;124(11):1665-1666.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Age-Related Macular Degeneration
Jager et al.
NEJM 2008;358:2606-2617.
FULL TEXT  

Multivitamin-multimineral supplements and eye disease: age-related macular degeneration and cataract
Seddon
Am. J. Clin. Nutr. 2007;85:304S-307S.
ABSTRACT | FULL TEXT  

A Clinician's View of the Molecular Genetics of Age-Related Maculopathy
Gorin
Arch Ophthalmol 2007;125:21-29.
ABSTRACT | FULL TEXT  

Heart outcomes prevention evaluation-the ongoing outcomes study, vitamin e, and age-related macular degeneration.
Pulido
Arch Ophthalmol 2006;124:1665-1665.
FULL TEXT  

Heart Outcomes Prevention Evaluation-The Ongoing Outcomes Study, Vitamin E, and Age-Related Macular Degeneration--Reply
Chew and Clemons
Arch Ophthalmol 2006;124:1665-1666.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.